0001209191-23-033723.txt : 20230602
0001209191-23-033723.hdr.sgml : 20230602
20230602162458
ACCESSION NUMBER: 0001209191-23-033723
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230602
DATE AS OF CHANGE: 20230602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fanucci Marsha
CENTRAL INDEX KEY: 0001298814
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37813
FILM NUMBER: 23989184
MAIL ADDRESS:
STREET 1: MILLENNIUM PHARMACEUTICALS, INC.
STREET 2: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001556263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453772460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-744-1340
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: LS22, Inc.
DATE OF NAME CHANGE: 20120815
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-01
0
0001556263
Syros Pharmaceuticals, Inc.
SYRS
0001298814
Fanucci Marsha
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
1
0
0
0
0
Common Stock
2023-06-01
4
A
0
4000
0.00
A
12000
D
Stock Option (right to buy)
3.70
2023-06-01
4
A
0
6000
0.00
A
2033-05-31
Common Stock
6000
6000
D
The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.
/s/ Todd Rosenthal, as attorney-in-fact
2023-06-02